Use of sildenafil in patients with cardiovascular disease
Main Authors: | Armênio Costa Guimarães, Marcus Vinícius Bolívar Malachias, Otávio Rizzi Coelho, Emílio Cesar Zilli, Rafael Leite Luna |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Cardiologia (SBC)
1999-12-01
|
Series: | Arquivos Brasileiros de Cardiologia |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X1999001200006 |
Similar Items
-
Polycystic Ovary Syndrome and Cardiovascular Diseases: Still an Open Door
by: Marcus Vinicius Bolivar Malachias
Published: (2019-04-01) -
Strategies for reducing cardiovascular mortality should go beyond control of classic risk factors
by: Marcus Vinícius Bolívar Malachias
Published: (2019-03-01) -
NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
by: Marcus Vinicius Bolivar Malachias, et al.
Published: (2022-05-01) -
The Challenges of Controlling Arterial Hypertension in the Elderly
by: Marcus Vinicius Bolivar Malachias -
Effect of sildenafil citrate on the cardiovascular system
by: K. Shinlapawittayatorn, et al.
Published: (2005-09-01)